Are PAH-targeted Therapies Beneficial for CTD-PAH?

In this video-based activity, Dr. Victor Tapson shares the importance of therapy selection for patients with pulmonary arterial hypertension associated with connective tissue disease. Providing real-world insight and key takeaways for application to clinical practice, Dr. Tapson discusses which PAH therapies are beneficial for patients with CTD-PAH and the importance of a multidisciplinary team while managing these patients.

The purpose of this activity is to enhance clinician skills in providing comprehensive and effective treatment for patients with CTD-PAH in order to improve patient outcomes. Through a review of the efficacy and safety data of traditional PAH therapies for treatment of CTD-PAH, this activity provides practical guidance to improve efficacy in patients who previously had attenuated responses to PAH therapies. Key attributes of a successful multidisciplinary team will be shared to enhance patient care.